1. Access to Mobile Health Interventions Among Patients Hospitalized With Heart Failure: Insights Into the Digital Divide From the CONNECT-HF mHealth Substudy.
- Author
-
Diamond JE, Kaltenbach LA, Granger BB, Fonarow GC, Al-Khalidi HR, Albert NM, Butler J, Allen LA, Lanfear DE, Thibodeau JT, Granger CB, Hernandez AF, Ariely D, and DeVore AD
- Subjects
- Humans, Patients, Heart Failure diagnosis, Heart Failure therapy, Digital Divide, Mobile Applications, Telemedicine
- Abstract
Competing Interests: Disclosures Dr Bradi B. Granger reports research funding through her institution from the American Heart Association, AstraZeneca, the Centers for Disease Control, the Alpha Phi Foundation, and the National Institutes of Health (NIH). Dr Fonarow reports consulting for Abbott, Amgen, AstraZeneca, Bayer, Cytokinetics, Eli Lilly, Janssen, Medtronic, Merck, Novartis, and Pfizer. Dr Albert reports consulting for American Regent, AstraZeneca, Boehringer Ingelheim, Boston Scientific, Cytokinetics, Eli Lilly, and Merck and received research support from AstraZeneca and Novartis. Dr Butler has served as a consultant for Abbott, American Regent, Amgen, Applied Therapeutic, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Cardiac Dimension, Cardior, CVRx, Cytokinetics, Edwards, Element Science, Innolife, Impulse Dynamics, Imbria, Inventiva, Lexicon, Lilly, LivaNova, Janssen, Medtronic, Merck, Occlutech, Novartis, Novo Nordisk, Pfizer, Pharmacosmos, Pharmain, Roche, Sequana, SQ Innovation, and Vifor. Dr Allen received grant funding from the NIH and the Patient Centered Outcomes Research Institute and consulting fees from ACI Clinical, Boston Scientific, Cytokinetics, and Novartis. Dr Lanfear is a consultant for Abbott Laboratories, Amgen, AstraZeneca, Cytokinetics, Illumina, Janssen, Martin Pharmaceuticals, Vicardia, and the Duke Clinical Research Institute (Novartis) and has participated in clinical research from Amgen, AstraZeneca, Bayer, Critical Diagnostics, Illumina, Lilly, Somalogic, and Janssen. Dr DeVore reports research funding through his institution from Biofourmis, Bodyport, Cytokinetics, American Regent Inc, NIH, the National Heart, Lung, and Blood Institute, Novartis, and Story Health and also provides consulting services for and receives honoraria from Abiomed, Cardionomic, LivaNova, Natera, NovoNordisk, Story Health, and Zoll. The other authors report no conflicts.
- Published
- 2024
- Full Text
- View/download PDF